Skip to main content

Featured

8.92m vaccine doses administered

About 8,923,300 doses of COVID-19 vaccines have been administered to the public, with about 4,570,000 people receiving their first dose and around 4,353,200 getting their second dose.   Among those given the first dose of vaccines, about 1,660,600 people have received the Sinovac jab and about 2,909,500 people got the BioNTech one.   For the second dose, about 1,587,200 people have received the Sinovac vaccine, while about 2,766,000 people have been administered the BioNTech jab.   About 9,300 people received jabs under the COVID-19 Vaccination Programme today.   Around 1,800 people received their first dose of the Sinovac vaccine and around 2,600 people received their second dose.   For the BioNTech vaccine, about 2,300 people received their first dose and around 2,800 people got their second dose.   The overall percentage of people who received the Sinovac vaccine at community vaccination centres is about 97%, while it is about 90% for the BioNTech one. http://dlvr.it/S9t

HK set to become tech hub

Research and development (R&D) is always the foundation of innovation and technology (I&T), and we have invested heavily in encouraging and supporting local R&D works. Apart from supporting R&D activities through various schemes, the Government has also been fostering technology transfer and realisation of R&D results. One of the good examples is to foster the development of local technology startups from our universities by launching the Technology Start-up Support Scheme for Universities under the Innovation & Technology Fund to support teams from our local universities, including Chinese University of Hong Kong (CUHK), in starting technology businesses and commercialising their R&D results. Annual funding provided to each university has been increased up to $8 million, and each startup may receive up to $1.5 million per year for a maximum of three years. Since its inception, the support scheme has provided funding support to 334 startups with a total amount of $250 million.        Quality infrastructure and facilities for R&D are also indispensable for promoting I&T. We have set up two InnoHK research clusters focusing on two major areas, namely healthcare technologies and artificial intelligence as well as robotics technologies. We aim to pool in top-notch researchers all over the world via this initiative to consolidate Hong Kong's leading position as the hub for global research collaboration. The first batch of some 20 R&D laboratories including world-renowned universities and research institutes, as well as our local universities, have begun operation in the Science Park. I am so grateful for the support and participation of CUHK in this InnoHK initiative. Last month, the Chief Executive visited the Microbiota I-Center, MagIC, and I am particularly impressed by the research team's vision to have a new pharmaceutical and healthcare frontier in Hong Kong and the Guangdong-Hong Kong-Macao Greater Bay Area (GBA).        Outstanding institutes and excellent researchers in Hong Kong will definitely have bigger roles to play on the road of building Hong Kong into an international I&T hub, leveraging the vast opportunities brought about by the National 14th Five-Year Plan and the GBA development. I sincerely hope that CUHK and the academia can seize every opportunity ahead and embrace the country's support, thereby bringing more impetus to the research and innovation sector in Hong Kong.   Secretary for Innovation & Technology Alfred Sit gave these remarks at the CUHK Innovation Day 2021 on September 23.
http://dlvr.it/S86yTx

Popular Posts